Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis.

By E. Baecklund, A. Iliadou, J. Askling, A. Ekbom, C. Backlin, F. Granath, A. Catrina, R. Rosenquist, N. Feltelius, C. Sundström and 1 more. Arthritis & Rheumatism, 2006

893 citations recorded by the source corpus.

Subfields: Oncology, Pathology and Forensic Medicine, Rheumatology

View Paper: https://www.semanticscholar.org/paper/5e161569e98e7a0dfa7d4663acddb93efea17830

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. J. Ludvigsson

In Rheumatology

1. D. Tracey
2. Lars Klareskog
3. J. Salfeld
4. P. Tak
5. E. Sasso

Citations in the corpus

• External review and validation of the Swedish national inpatient register (2011, background): “5) In 40 of the 386 cases with lymphoma, medical records did not include enough information to evaluate whether the RA criteria of the American College of Rheumatology were fulfilled but all available information supported the diagnosis of RA Baecklund [22] 16508929 2006 MR”
• Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. (2008, neutral): “Median (range) 60 (17-89) 58 (16-96) Education/SES†”
• Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. (2008, background): “However, there is strong evidence that disease activity is a driving force behind the increased risk for lymphomas in patients with RA irrespective of the treatment (Baecklund et al., 1998, 2004; Wolfe & Michaud, 2004; Baecklund et al., 2006).”